Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OXiGENE Inc (NASDAQ:OXGN)

0.54
Delayed Data
As of Feb 12
 +0.04 / +8.00%
Today’s Change
0.49
Today|||52-Week Range
1.97
-28.94%
Year-to-Date
No recent news for OXiGENE Inc.

Today’s Trading

Previous close0.50
Today’s open0.50
Day’s range0.50 - 0.54
Volume174,406
Average volume (3 months)171,743
Market cap$14.3M
Dividend yield--
Data as of 3:59pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+83.94%
Earnings growth (this year)+29.33%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book0.39

Competitors

 Today’s
change
Today’s
% change
ROSGRosetta Genomics Ltd+0.01+1.27%
RGBPRegen BioPharma Inc-0.00-0.97%
RXIIRxi Pharmaceuticals ...+0.00+0.11%
WGBSWaferGen Bio-systems...-0.01-1.10%
Data as of 3:59pm ET, 02/12/2016

Financials

Next reporting dateMarch 15, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$0.00
Annual profit (last year)-$12.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William D. Schwieterman
Chief Financial &
Accounting Officer
Matthew M. Loar
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers